Table of Contents
- Scope and Themes
- What you need to know
- Definition
- Data for this report
- Abbreviations and terms
- Abbreviations
- Terms
- Executive Summary, Part I: Market Wide Issues
- Access to healthcare the primary obstacle to increased sales
- Consumers losing faith in pharmaceutical companies
- OTC and Rx medication increasingly competitive
- Attentiveness to advertising dependent on prevalence of condition
- Younger respondents more attentive, but less able to receive prescriptions
- Consumers more active in researching conditions and treatments
- Selling the branded product when generics are available
- Healthcare Coverage
- Introduction
- Access to healthcare coverage
- Figure 1: Access to health insurance, November 2007, and May 2006-June
2007
- Figure 2: Rx prevalence of usage, by type of medical insurance, November
2007
- Distrust of Pharmaceutical Companies
- Consumer distrust of pharmaceutical companies
- Figure 3: Attitudes toward prescription medicine, by availability of
medical insurance, November 2007
- Trust for pharmaceutical ads by age
- Figure 4: Attitudes regarding trust and pharmaceutical companies, by
age, November 2007
- Doctors reject pharmaceutical sales tactics
- Consumer attitudes toward their doctors
- Figure 5: Attitudes towards doctors' roles in choosing pharmaceuticals,
June 2002-May 2003, and May 2006 to June 2007
- Fear of side effects
- Figure 6: Attitudes regarding side effects of drugs, by gender, May 2006
to June 2007
- Attitudes to media presentation of side effects
- Figure 7: Attitudes regarding the presentation of side effects in D2C
advertising, by age, November 2007
- Competition from OTC medication
- Preferences between OTC and Rx medication
- Figure 8: Attitudes toward OTC medicine, by age, May 2006 to June 2007
- Figure 9: Choice of OTC medicine over prescription, by age, November
2007
- Comparison of Rx usage across illnesses in the Internet population
- Figure 10: Use of prescription medication, by condition, November 2007
- Competition from/Attitudes to Alternative Medicine
- Figure 11: Attitudes toward alternative medicine, June 2002-May 2003,
May 2004-May 2005, May 2006 to June 2007
- Figure 12: Attitudes toward alternative medicine, by age, November 2007
- Attentiveness to Advertising
- Introduction
- Figure 13: Paying attention to D2C advertising, by type of medication,
November 2007
- Figure 14: Attentiveness to pharmaceutical ads, by gender, November 2007
- Figure 15: Attentiveness to pharmaceutical ads, by age, November 2007
- Figure 16: Attentiveness to pharmaceutical ads, by race/ethnicity,
November 2007
- Figure 17: Attentiveness to pharmaceutical ads, by student status,
November 2007
- Why ads are watched
- Figure 18: Reasons for watching drug ads, November 2007
- Figure 19: Reasons for watching drug ads, by age, November 2007
- The Consumer' s Research Process
- General health research
- Figure 20: Ways of reseaching health information, by gender, May 2006 to
June 2007
- Figure 21: Ways of researching health information, 2003 vs. 2007
- Figure 22: Ways of researching health information, by age, May 2006-June
2007
- Researching healthcare treatments
- Figure 23: Researching pharmaceuticals and treatments, 2003 vs. 2007
- Figure 24: Researching pharmaceuticals and treatments, by gender, May
2006 to June 2007
- Buying Generic vs. Brand Name
- Figure 25: Attitudes to brand-name drugs, May 2006 to June 2007
- Figure 26: Attitudes towards name brand and generic drugs, November 2007
- Figure 27: Attitudes towards name brand and generic drugs, by
race/ethnicity, November 2007
- Executive Summary, Part II: Prevalence of Treatment of Specific Conditions
- Use of Rx medication varies based on effectiveness of OTC treatment
- Substantial opportunity exists in overweight/obesity and herpes
- Potential for viral marketing apparent
- Depression category leads in sales, sleep aids in ad spend
- Sexual dysfunction is not gender-specific
- Some suffering from allergies not aware that they have them
- Psychiatric medications continue to face obstacles
- A large body of sufferers is not being treated in every condition
- Making men comfortable talking about depression
- Where does trouble concentrating end and ADHD begin?
- Bulleted check list for websites
- Prevalence of Conditions and Use of Rx Treatments
- Introduction
- Figure 28: Prevalence of ailments trended and percentage with ailments
using prescription medication, 2003-07
- Substantial opportunity in drugs to combat obesity
- Prescription drug use for allergies declining
- Emphasis on responsibility should grow herpes market
- Depression: Penetration says more about the competition than about the
drug
- Internet population
- Figure 29: Ailments, have, have had, or friend or family has, November
2007, and May 2006 to june 2007
- Comparison of Rx usage across conditions
- Figure 30: Use of prescription medication by condition, November 2007
(GF) and May 2006-June 2007 (NCS)
- Prevalence of conditions suffered in Internet population by demographics
- Figure 31: Conditions suffered (self-reported), by age, November 2007
- Figure 32: Conditions suffered (self-reported), by gender, November 2007
- Figure 33: Conditions suffered (self-reported), by household income,
November 2007
- Figure 34: Conditions suffered (self-reported), by race/Hispanic origin,
November 2007
- Sales and Advertising Spend
- Sales
- Figure 35: Sales of 20 leading pharmaceutical products for six
conditions, 2004 and 2006
- Depression medication sales
- ADHD medication
- Allergy medications
- Sleep medications
- Figure 36: Ad spend on sleep medication, 2005 and 2006
- Sexual Dysfunction
- Introduction
- Figure 37: Suffer or have suffered from sexual dysfunction, by
demographic, November 2007
- Treatment of sexual dysfunction
- Figure 38: Sexual dysfunction treatment used, by household income,
November 2007
- Sexual dysfunction medications
- Viagra
- Figure 39: Pfizer Viagra Advertisement
- Levitra
- Figure 40: Bayer Levitra Advertisement
- Cialis
- Figure 41: Lilly Cialis Advertisement
- Pollen Allergies
- Introduction
- Figure 42: Suffered from nasal allergies/hay fever in last 12 months, by
demographic, May 2006 to June 2007
- Treatment of allergies
- Figure 43: Nasal allergy treatment used, by age, November 2007
- Figure 44: Allergy treatment used, by race/Hispanic origin, November
2007
- Notes on OTC treatment
- Allergy shots
- Nasal airway surgeries
- Allergy medications
- Nasonex
- Figure 45: Schering-Plough Nasonex Advertisement
- Allegra
- Clarinex
- Flonase
- Overweight and Obesity
- Introduction
- Figure 46: Prevalence of being 30 pounds overweight in the last 12
months, by key demographics, May 2006 to June 2007
- Xenical
- Competition from gastric bypass surgery
- Attitudes Towards Sleep Aids and Psychiatric Drugs
- Figure 47: Attitudes towards psychiatric illnesses and drugs and sleep
aids, November 2007
- Depression
- Introduction
- Prevalence and treatment with Rx medication by demographic
- Figure 48: Incidence of depression, and Rx treatment, by demographic,
November 2007, and May 2006-June 2007
- Rx vs. other methods of treatment
- Figure 49: Depression treatment used, by age, November 2007
- Figure 50: Depression treatment used, by race/ethnicity, November 2007
- Switching depression medication
- Figure 51: Reasons to change depression medication, by age, November
2007
- Depression medications
- Effexor
- Figure 52: Effexor advertisement
- Zoloft
- Wellbutrin
- Cymbalta
- Figure 53: Eli Lilly Cymbalta Advertisement
- Anxiety
- Introduction
- Figure 54: Suffer or have suffered from general or social anxiety, by
demographic, November 2007, and May 2006-June 2007
- Treatment of general anxiety
- Figure 55: General anxiety treatment used, by age, November 2007
- Treatment of social anxiety
- Figure 56: Social anxiety treatment used, by race/ethnicity, November
2007
- Switching anxiety medication
- Figure 57: Reasons to change anxiety medication, November 2007
- Adhd
- Prevalence
- Figure 58: Suffers or has suffered from ADHD or trouble concentrating,
by age, November 2007
- Treatment of ADHD
- Figure 59: ADHD treatment used, by age, November 2007
- ADHD medications
- Concerta
- Adderall XR
- Strattera
- Sleep Disorders
- Introduction
- Figure 60: Suffered from sleep disorders in last 12 months, by age and
gender, May 2006 to June 2007, and November 2007
- Treatment of sleep-related problems
- Figure 61: Sleep-related problem treatment used, by gender, November
2007
- Figure 62: Sleep disorder treatment used, by age, November 2007
- Treatments for sleep apnea
- Sleep disorder medications
- Lunesta
- Figure 63: Sepracor Lunesta Advertisement
- Ambien
- Figure 64: Sanofi-Aventis Ambien CR Advertisement
- Figure 65: Sanofi-Aventis Ambien CR Advertisement
- Rozerem
- Requip
- Figure 66: GlaxoSmithKline Requip Advertisement
- Appendix: Trade Associations
|
Related Report
|
View Cart
